Cancer evolution is central to poor outcomes of cancer therapies, enabling tumour progression and the acquisition of drug resistance. Joint efforts of evolutionary biologists, oncologists and cancer researchers are necessary to understand the principles of cancer evolution and to derive therapeutic strategies that can control it.
Access options
Subscribe to Journal
Get full journal access for 1 year
$99.00
only $8.25 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
from$8.99
All prices are NET prices.
References
- 1.
Gerlinger, M. et al. Annu. Rev. Genet. 48, 215–236 (2014).
- 2.
Gerlinger, M. et al. Nat. Genet. 46, 225–233 (2014).
- 3.
Bettegowda, C. et al. Sci. Transl. Med. 6, 224ra224 (2014).
- 4.
Gundem, G. et al. Nature 520, 353–357 (2015).
- 5.
Prasad, V. Nature 537, S63 (2016).
- 6.
Matsushita, H. et al. Nature 482, 400–404 (2012).
- 7.
Siravegna, G. et al. Nat. Med. 21, 795–801 (2015).
- 8.
Gao, R. et al. Nat. Genet. 48, 1119–1130 (2016).
- 9.
Jamal-Hanjani, M. et al. PLoS Biol. 12, e1001906 (2014).
- 10.
Barber, L. J., Davies, M. N. & Gerlinger, M. Curr. Opin. Genet. Dev. 30, 1–6 (2015).
- 11.
Williams, M. J., Werner, B., Barnes, C. P., Graham, T. A. & Sottoriva, A. Nat. Genet. 48, 238–244 (2016).
- 12.
Lipinski, K. A. et al. Trends Cancer 2, 49–63 (2016).
- 13.
Enriquez-Navas, P. M. et al. Sci. Transl. Med. 8, 327ra324 (2016).
- 14.
Harris, R. S. Breast Cancer Res. 17, 8 (2015).
- 15.
Drake, C. G., Lipson, E. J. & Brahmer, J. R. Nat. Rev. Clin. Oncol. 11, 24–37 (2014).
Author information
Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
von Loga, K., Gerlinger, M. Cancer (r)evolution. Nat Ecol Evol 1, 1051–1052 (2017). https://doi.org/10.1038/s41559-017-0252-1
Published:
Issue Date:
Further reading
-
A rewiring model of intratumoral interaction networks
Computational and Structural Biotechnology Journal (2020)
-
Aligning functional network constraint to evolutionary outcomes
BMC Evolutionary Biology (2020)
-
Targeting cancer epigenetics with CRISPR-dCAS9: Principles and prospects
Methods (2020)
